Use of medicinal composition

A technology of composition and medicine, applied in the field of medicine

Inactive Publication Date: 2010-05-12
TIANJIN TASLY PHARMA CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the research on the pharmaceutical composition mainly focuses on the treatment of dementia, chronic dementia, vascular dementia, senile dementia, and Alzheimer's disease. There is no report on the application of the pharmaceutical composition composed of borneol in antioxidant medicine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of medicinal composition
  • Use of medicinal composition
  • Use of medicinal composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] Embodiment 1: the preparation of dropping pill

[0065] Take selected Chinese medicine raw materials with the following weights and go through screening, purification and crushing for later use:

[0066] Astragalus 16.7g, Salvia 16.7g, Chuanxiong 10g, Atractylodes 10g, Shichangpu 10g, Coptis 3.3g, Borneol 0.0667g;

[0067] Take astragalus and dandelion and add 10 times the amount of water, reflux and extract twice, 1.5 hours each time, filter the extract, and set aside; add 10 times the amount of water to Chuanxiong, Atractylodes atractylodes, and Shichangpu, extract the volatile oil with a volatile oil extractor for 8 hours, and use the volatile oil for later use. Filter out the water extract, add 10 times the amount of water to extract the dregs of the medicine for 1.5 hours, combine the water extract, filter and combine with the Astragalus miltiorrhiza extract and concentrate under reduced pressure to 1ml approximately equal to 1g crude drug, let cool, add 95% ethano...

Embodiment 2

[0070] Embodiment 2: the preparation of granule

[0071] Take 25.5g of Astragalus, 25.5g of Salvia, 15g of Chuanxiong, 15g of Atractylodes atractylodes, 15g of Shichangpu, 7.5g of Coptis chinensis, and 0.8g of borneol for later use;

[0072] Take astragalus and dandelion and add 14 times the amount of water, reflux and extract twice, each time for 3 hours, filter the extract, and set aside; add 12 times the amount of water to Chuanxiong, atractylodes, and calamus, extract the volatile oil with a volatile oil extractor for 12 hours, and use the volatile oil for later use. Filter out the water extract, add 12 times the amount of water to extract the dregs of the medicine for 3 hours, combine the water extract, filter and combine with the extract of Astragalus miltiorrhiza miltiorrhiza and concentrate under reduced pressure to 1ml, which is approximately equal to 1.5g of crude drug, let it cool, add 98% ethanol, and make Alcohol concentration is 60%, after standing overnight, fil...

Embodiment 3

[0075] Embodiment 3: the preparation of capsule

[0076] Take 8.5g Astragalus, 8.5g Salvia, 5g Chuanxiong, 5g Atractylodes, 5g Shichangpu, 2g Coptis, and 0.01g borneol for later use;

[0077] Take astragalus and dandelion and add 8 times the amount of water, reflux and extract twice, each time for 2 hours, filter the extract, and set aside; add 8 times the amount of water to Chuanxiong, Atractylodes atractylodes, and Shichangpu, extract the volatile oil with a volatile oil extractor for 4 hours, and use the volatile oil for later use. Filter out the water extract, extract the dregs with 10 times the amount of water for 2 hours, combine the water extract, filter and combine with the Astragalus miltiorrhiza extract and concentrate under reduced pressure to 1ml approximately equal to 0.5g crude drug, let cool, add 90% ethanol to make Alcohol concentration is 60%, after standing overnight, filter, reclaim ethanol until 1ml is approximately equal to 3g crude drug, add 95% ethanol, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An anti-oxidizing Chinese medicine for treating cardiovascular and cerebrovascular diseases is prepared from 7 Chinese-medicinal materials including astragalus root, red sage root, Chuan-xiong rhizome, rehmannia root, etc.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the application of a pharmaceutical composition in the preparation of antioxidant drugs. Background technique [0002] Astragalus membranaceus is an important medicine for invigorating qi in traditional Chinese medicine. It is sweet and slightly warm. Diabetes, chronic ulcers and other diseases. In recent years, it has been clinically used to treat hypertension and acute and chronic nephritis. Modern studies have found that the "Qi-tonifying" effect of Astragalus is mainly manifested in enhancing immunity, improving heart function and blood microcirculation. Recent studies at home and abroad have shown that Astragalus has the effect of lowering blood pressure. The chemical composition of Astragalus is complex, including saponins, polysaccharides, flavonoids, various amino acids, trace elements, choline, β-sitosterol, betaine, etc. Previous research results have shown that ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/888A61K36/718A61K36/53A61K36/481A61K36/284A61K36/236A61K31/045A61K9/00A61P9/12A61P9/10
Inventor 李永强郑永锋李旭
Owner TIANJIN TASLY PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products